Home/Pipeline/RHYTHMS (Eurostars Project)

RHYTHMS (Eurostars Project)

Not Specified

ResearchActive

Key Facts

Indication
Not Specified
Phase
Research
Status
Active
Company

About Stemmatters

Stemmatters is a private, revenue-generating CDMO based in Guimarães, Portugal, offering end-to-end contract development and cGMP manufacturing solutions for regenerative medicine products. It operates as a one-stop shop, providing services in contract development, analytical testing, formulation development, and manufacturing for cell therapies, including iPSC-derived products and CAR-T cells. The company is actively engaged in collaborative R&D projects and partnerships, positioning itself as a key European player in the advanced therapy CDMO landscape.

View full company profile

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved